Our results indicate that genetic ablation of Daxx up-regulated the p-TBK1 and p-IRF3 expression levels to sensitize chemotherapy, suggesting that Daxx is a negative regulator of the STING signal, thereby slowing tumor growth in vivo. The gene discussed is DAXX; the disease is neoplasm.